02-25 20:01
Twenty-one patients (64%) were previously treated with camrelizumab combined chemotherapy and 12 with other immunochemotherapy.
//@比尔吉沃特TIGIT:回复@Finn_Hudson:baseline的话,恒瑞的是全部PD1+化疗经治,更差;2821只有部分PD1+化疗经治,是更好的。
有球友私信问我$迈威生物-U(SH688062)$ 这个数据是不是大超预期,说下我的观点:
第一,先说结论,【略微失望】,更别提“超预期”了;but今晚我要好好学习下FTD是依据什么来评定,是不是我们看不到的信息和资料...
第二,讨论下细节(欢迎大佬们补充,毕竟之前没详细看过这个适应...
Twenty-one patients (64%) were previously treated with camrelizumab combined chemotherapy and 12 with other immunochemotherapy.
NCT03736863这个
看到了,1L免疫治疗失败的是指1L用了ICI+chemo